MainBusinessBiotechnology and PharmaceuticalsPharmaceuticals › Akorn, Inc.

Akorn, Inc.

Edit Page
Report
Scan day: 05 February 2014 UTC
8
Virus safety - good
Description: Offers contract manufacture of diagnostics and therapies, with expertise in ophthalmic and parenteral healthcare. Details of formulation and lyophilization cycle development, investor relations, and facilities in Illinois and Somerset, New Jersey. (Nasdaq: AKRN)
Akorn - Akorn Pharmaceuticals - Advancing the New Vision | Sterile Ophthalmic and Injectable Pharmaceuticals January Free Shipping Special From Akorn... Akorn Acquires Three Branded Ophthalmic Products from Merck ...
Size: 216 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Akorn - Akorn Pharmaceuticals - Advancing the New Vision | Sterile Ophthalmic and Injectable Pharmaceuticals
Keywords:akorn, specialty, pharmaceutical, company, development, contract, manufacturing, branded, products, vaccine, biologics, generics, ocular anesthesia, opthalmics, hospital drugs, cogentin, nembutal, sodium diuril, injectables, barbituates, ahnesthetics, nembutal, akten, ic-green, ak-flour
Description:Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology,retina, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.
IP-address:69.172.200.247

WHOIS Info

NS
Name Server: NS73.WORLDNIC.COM
Name Server: NS74.WORLDNIC.COM
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 07-nov-1997
Expiration Date: 06-nov-2015